Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. - Wikidata - awgldk - TriplyDB

Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.

Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.

http://www.wikidata.org/entity/Q33427828

about

Vascular complications associated with transcatheter aortic valve replacement.Dynamic Sheaths, in the Nick of Time or Past Their Prime?

P2860

Q39299038-70C4C0FB-D688-49D8-A4DB-A8072A7CA157 Q47917481-F0AC51CE-B5B8-4912-83DD-52D49C0F456E

P2860

Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.

http://www.wikidata.org/entity/Q33427828

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Vascular complication can be m ...... self-expanding bioprosthesis.

@ast

Vascular complication can be m ...... self-expanding bioprosthesis.

@en

type

label

Vascular complication can be m ...... self-expanding bioprosthesis.

@ast

Vascular complication can be m ...... self-expanding bioprosthesis.

@en

prefLabel

Vascular complication can be m ...... self-expanding bioprosthesis.

@ast

Vascular complication can be m ...... self-expanding bioprosthesis.

@en

P1433

Q33427828-20B38750-FF3A-4085-8200-A0F2CFAF9BAB

P1476

Q33427828-6542928A-40AE-42D3-9A33-1C744526D5E3

P2093

Q33427828-06F75BBB-712F-4FF7-B75C-F501068D93DD

Q33427828-2A0B18EF-AC0D-48A5-9C62-422507924A9B

Q33427828-3BE60031-843E-4F14-94DB-9FC0F596EE07

Q33427828-40635ECA-889C-45CE-AF68-E7AFC533B8BB

Q33427828-7E5CB044-06CA-4A99-A062-43502BAEBB08

Q33427828-8DCC1537-4DED-4523-8ACA-1EC7FD912B2F

Q33427828-A9F5B062-58A7-4F52-B4C7-217C0EA6910F

Q33427828-BBDA92C2-51A2-49DA-B282-67DE47FA3008

Q33427828-C40AD9F1-76F8-4F5F-9F8D-11F54F5173F6

Q33427828-C8589511-CF47-4319-9870-9296236FC766

P2860

Q33427828-0736780B-9BC5-4FBF-926B-F04D2B92DA9C

Q33427828-0C16D008-66CA-4BB6-B430-F8F6F3ED9C84

Q33427828-196E2D42-C20E-4C84-92D3-1938FE064061

Q33427828-1AFE449E-7B49-4CF3-86FE-815461B37273

Q33427828-3195853D-40CE-48B6-BD53-5BBB0688A1A8

Q33427828-44F88690-D488-4164-A153-C54F4DF04F0F

Q33427828-4525DA92-6A57-4E2D-93DA-2330731E83AD

Q33427828-5BA24C48-E9F8-4902-9F85-E87C6598A152

Q33427828-788E89FA-A097-4B8A-B178-B208CFF9347B

Q33427828-8A2EC11C-1197-45C6-B8A1-C5B6F2A416D4

P304

Q33427828-A1A198CD-9532-4255-A379-66D04026623D

P31

Q33427828-ABB7BC83-B3A0-49FD-8A65-5D3680B5624A

P356

Q33427828-B7651A30-036C-4871-B13C-A95FA4B88F40

P433

Q33427828-E9B6C81A-229C-4D8D-BD7F-18651C07886F

P478

Q33427828-84C67A06-637C-48F2-B04F-FAAC204225EB

P577

Q33427828-4C10AB1D-4737-4645-9BBD-2907D9F6AAD0

P698

Q33427828-4B62A5C9-A288-44FC-8678-40E2F834A53B

P356

P1433

Catheterization and Cardiovascular Interventions

P1476

Vascular complication can be m ...... self-expanding bioprosthesis.

@en

P2093

Basel Ramlawi

http://www.w3.org/2001/XMLSchema#string

Cenap Undemir

http://www.w3.org/2001/XMLSchema#string

Colin M Barker

http://www.w3.org/2001/XMLSchema#string

Gilbert H L Tang

http://www.w3.org/2001/XMLSchema#string

Hasan Ahmad

http://www.w3.org/2001/XMLSchema#string

Manuel Reyes

http://www.w3.org/2001/XMLSchema#string

Martin Cohen

http://www.w3.org/2001/XMLSchema#string

Michael J Reardon

http://www.w3.org/2001/XMLSchema#string

Neal S Kleiman

http://www.w3.org/2001/XMLSchema#string

Steven L Lansman

http://www.w3.org/2001/XMLSchema#string

P2860

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Vascular access in transcatheter aortic valve implantation.

Beyond PARTNER: appraising the evolving trends and outcomes in transcatheter aortic valve replacement.

A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular disease and tortuosity.

Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.

Outcomes following transcatheter aortic valve replacement in the United States.

Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.

Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

P304

135-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.26336

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26603266

http://www.w3.org/2001/XMLSchema#string